Not Signed In - 15 European Countries Approve Use Of Relenza® In Prevention Of Influenza A And B
Sat, 02 Sep 2006 07:00 PM EST
... GlaxoSmithKline (GSK) today announces that it has received approval from European Regulators in 15 EU countries for use of its anti-viral Relenza ® (zanamivir for inhalation) in the prevention (prophylaxis) of influenza A and B in adults and children 5 years of age and above.Approval was also received today for the treatment of influenza in children 5 years of age and above. [click link for full article] ...
Related Topics
- Influenza
- Injury/ Injury Prevention
- Prevention
- Disease Prevention
- Influenza and Colds
- CA 15-3
- Safety Issues
- Heart Diseases--Prevention
- Avian Influenza
- Atherosclerosis
- Black Alder
- STD Prevention
- Zinc Salts tablets or capsules
- Influenza Virus Vaccine
- Influenza Vaccines
- Influenza (Flu)
- Influenza (flu) Vaccine
- Influenza Surveillance Data
- H1N1 (swine) influenza
- Bird flu (avian influenza)
email this page
print this page
bookmark this page
feedback on this page
